SONOMABIO Trademark

Trademark Overview

On Thursday, July 14, 2022, a trademark application was filed for SONOMABIO with the United States Patent and Trademark Office. The USPTO has given the SONOMABIO trademark a serial number of 97503974. The federal status of this trademark filing is REGISTERED as of Tuesday, July 8, 2025. This trademark is owned by Sonoma Biotherapeutics, Inc.. The SONOMABIO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, cell therapy to treat diseases associated with inflammation such as autoimmune and neurodegenerative diseases, and biologic medications that reduce effector cells involved in diseases associated with inflammation, particularly, autoimmune and neurodegenerative diseases
sonomabio

General Information

Serial Number97503974
Word MarkSONOMABIO
Filing DateThursday, July 14, 2022
Status700 - REGISTERED
Status DateTuesday, July 8, 2025
Registration Number7859998
Registration DateTuesday, July 8, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 6, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, cell therapy to treat diseases associated with inflammation such as autoimmune and neurodegenerative diseases, and biologic medications that reduce effector cells involved in diseases associated with inflammation, particularly, autoimmune and neurodegenerative diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 4, 2022
Primary Code005
First Use Anywhere DateMonday, August 12, 2024
First Use In Commerce DateMonday, August 12, 2024

Trademark Owner History

Party NameSonoma Biotherapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameSonoma Biotherapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameSonoma Biotherapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Thursday, August 4, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 18, 2022NEW APPLICATION ENTERED
Friday, April 28, 2023ASSIGNED TO EXAMINER
Wednesday, May 3, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 17, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 6, 2023PUBLISHED FOR OPPOSITION
Tuesday, June 6, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 1, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, January 10, 2024SOU EXTENSION 1 FILED
Wednesday, January 10, 2024SOU EXTENSION 1 GRANTED
Wednesday, June 19, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, June 19, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 19, 2024SOU EXTENSION 2 GRANTED
Wednesday, June 19, 2024SOU EXTENSION 2 FILED
Monday, January 13, 2025SOU TEAS EXTENSION RECEIVED
Monday, January 13, 2025SOU EXTENSION 3 FILED
Monday, January 13, 2025SOU EXTENSION 3 GRANTED
Monday, March 3, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 4, 2025USE AMENDMENT FILED
Wednesday, March 5, 2025TEAS STATEMENT OF USE RECEIVED
Thursday, May 29, 2025STATEMENT OF USE PROCESSING COMPLETE
Thursday, May 29, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 10, 2024SOU TEAS EXTENSION RECEIVED
Friday, January 12, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 9, 2025NON-FINAL ACTION E-MAILED
Monday, June 9, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 9, 2025SU - NON-FINAL ACTION - WRITTEN
Monday, June 9, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 16, 2025ASSIGNED TO LIE
Wednesday, June 18, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 18, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 18, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, July 8, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, July 8, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, July 16, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Related Keywords

sonomabio diseases associated inflammation autoimmune neurodegenerative medications reduce particularly involved cells